Implications of Th1 and Th17 cells in pathogenesis of oral lichen planus

Abstract

Oral lichen planus (OLP) is considered a T cell-mediated autoimmune disease with unknown aetiology. T helper cells appear to play an important role in the pathogenesis of OLP. We investigated the possible role of T helper cells, Th1 and Th17, in the lesions and circulation of patients with OLP. Forty patients with OLP and 15 healthy volunteers were recruited. Double immunofluorescence staining was used to detect Th1 and Th17 cells in the OLP lesions, and intracellular cytokine staining and flow cytometry to evaluate the proportion of Th1 and Th17 cells in peripheral blood. The levels of serum interferon (IFN)-γ and interleukin (IL)-17 were assessed by using an enzyme-linked immunosorbent assay. It was found that Th17 cells, as well as Th1 cells, were present in OLP lesions. The proportion of peripheral Th1 and Th17 cells was significantly increased in patients with OLP. The proportion of Th17 cells in atrophic-erosive OLP was elevated as compared with that in reticular OLP. Serum IL-17 levels in OLP patients were significantly higher than in controls, and those in the atrophic-erosive OLP group were increased as compared with the reticular OLP group. However, the levels of serum IFN-γ were slightly decreased in OLP patients. Our data suggested that Th1 and Th17 cells in the local lesions and peripheral blood may be associated with the pathogenesis of OLP, and that IL-17 may be an important proinflammatory cytokine in OLP. These findings enhance our understanding of OLP pathogenesis.

Keywords

interferon-γ / interleukin-17 / oral lichen planus / Th1 / Th17

References

[1] IngafouM., LeaoJ.C., PorterS.R., et al.. Oral lichen planus: a retrospective study of 690 British patients. Oral Dis, 2006, 12(5): 463-468

[2] SugermanP.B., SavageN.W., WalshL.J., et al.. The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med, 2002, 13(4): 350-365

[3] KhanA., FarahC.S., SavageN.W., et al.. Th1 cytokines in oral lichen planus. J Oral Pathol Med, 2003, 32(2): 77-83

[4] Simark-MattssonC., BergenholtzG., JontellM., et al.. Distribution of interleukin-2, -4, -10, tumour necrosis factor-alpha and transforming growth factor-beta mRNAs in oral lichen planus. Arch Oral Biol, 1999, 44(6): 499-507

[5] LuR., ZhouG., DuG., et al.. Expression of T-bet and GATA-3 in peripheral blood mononuclear cells of patients with oral lichen planus. Arch Oral Biol, 2011, 56(5): 499-505

[6] PeneJ., ChevalierS., PreisserL., et al.. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol, 2008, 180(11): 7423-7430

[7] BrandS.. Crohn’s disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn’s disease. Gut, 2009, 58(8): 1152-1167

[8] KornT., BettelliE., OukkaM., et al.. IL-17 and Th17 Cells. Annu Rev Immunol, 2009, 27: 485-517

[9] MaruyamaT., KonoK., MizukamiY., et al.. Distribution of Th17 cells and FoxP3(+) regulatory T cells in tumor-infiltrating lymphocytes, tumor-draining lymph nodes and peripheral blood lymphocytes in patients with gastric cancer. Cancer Sci, 2010, 101(9): 1947-1954

[10] LowesM.A., KikuchiT., Fuentes-DuculanJ., et al.. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol, 2008, 128(5): 1207-1211

[11] SontheimerR.D.. Lichenoid tissue reaction/interface dermatitis: clinical and histological perspectives. J Invest Dermatol, 2009, 129(5): 1088-1099

[12] ZhangL., YangX.Q., ChengJ., et al.. Increased Th17 cells are accompanied by FoxP3(+) Treg cell accumulation and correlated with psoriasis disease severity. Clin Immunol, 2010, 135(1): 108-117

[13] Charazinska-CarewiczK., GanowiczE., KrolM., et al.. Assessment of the peripheral immunocompetent cells in patients with reticular and atrophic-erosive lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2008, 105(2): 202-205

[14] LiuG.X., SunJ.T., YangM.X., et al.. OPN promotes survival of activated T cells by up-regulating CD44 in patients with oral lichen planus. Clin Immunol, 2011, 138(3): 291-298

[15] van der MeijE.H., van der WaalI.. Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. J Oral Pathol Med, 2003, 32(9): 507-512

[16] TaoX.A., XiaJ., ChenX.B., et al.. FOXP3 T regulatory cells in lesions of oral lichen planus correlated with disease activity. Oral Dis, 2010, 16(1): 76-82

[17] RobertsonD., SavageK., Reis-FilhoJ.S., et al.. Multiple immunofluorescence labelling of formalin-fixed paraffin-embedded (FFPE) tissue. BMC Cell Biol, 2008, 9: 13

[18] LodiG., ScullyC., CarrozzoM., et al.. Current controversies in oral lichen planus: report of an international consensus meeting. Part 1. Viral infections and etiopathogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2005, 100(1): 40-51

[19] SzaboS.J., SullivanB.M., StemmannC., et al.. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science, 2002, 295(5553): 338-342

[20] YamamotoT., YonedaK., UetaE., et al.. Cellular immunosuppression in oral lichen planus. J Oral Pathol Med, 1990, 19(10): 464-470

[21] KaragouniE.E., DotsikaE.N., SklavounouA.. Alteration in peripheral blood mononuclear cell function and serum cytokines in oral lichen planus. J Oral Pathol Med, 1994, 23(1): 28-35

[22] HirotaK., HashimotoM., YoshitomiH., et al.. T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. J Exp Med, 2007, 204(1): 41-47

[23] TzartosJ.S., FrieseM.A., CranerM.J., et al.. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am J Pathol, 2008, 172(1): 146-155

[24] ElsonC.O., CongY., WeaverC.T., et al.. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology, 2007, 132(7): 2359-2370

[25] LugerD., SilverP.B., TangJ., et al.. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med, 2008, 205(4): 799-810

[26] StromnesI.M., CerrettiL.M., LiggittD., et al.. Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat Med, 2008, 14(3): 337-342

[27] O’ConnorR.A., PrendergastC.T., SabatosC.A., et al.. Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. J Immunol, 2008, 181(6): 3750-3754

[28] AnnunziatoF., CosmiL., SantarlasciV., et al.. Phenotypic and functional features of human Th17 cells. J Exp Med, 2007, 204(8): 1849-1861

[29] YamadaH., NakashimaY., OkazakiK., et al.. Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis. Ann Rheum Dis, 2008, 67(9): 1299-1304